申请人:Azora Therapeutics, Inc.
公开号:US11154533B2
公开(公告)日:2021-10-26
Compositions and methods for treating skin conditions, ailments or diseases, such as autoinflammatory skin diseases such as psoriasis, dermatitis, pyoderma gangrenosum, palmoplantar pustulosis, prurigo nodularis and/or hidradenitis suppurativa, are described. The compositions comprise an agent that modulates the aryl hydrocarbon receptor, in particular an agent that agonizes the receptor. In one embodiment, the agent is indigo or a derivative of indigo, such as indirubin.
本文描述了用于治疗皮肤状况、病痛或疾病的组合物和方法,例如牛皮癣、皮炎、脓疱疮、掌跖脓疱病、结节性瘙痒症和/或化脓疱性皮炎等自身炎症性皮肤病。这些组合物包括一种调节芳基烃受体的制剂,特别是一种激动受体的制剂。在一个实施方案中,药剂是靛蓝或靛蓝的衍生物,如靛蓝素。